Anil Sood, MD

The University of Texas MD Anderson Cancer Center

Dr. Sood is Professor and Vice Chair for Translational Research in the Department of Gynecologic Oncology and Reproductive Medicine and holds a joint appointment in the Department of Cancer Biology at The University of Texas MD Anderson Cancer Center. He is Director of the Blanton-Davis Ovarian Cancer Research Program and Co-Director of the Center for RNA Interference and Non-Coding RNA.

He completed his Fellowship in Gynecologic Oncology at the University of Iowa Hospitals and Clinics. Dr. Sood received the GCF/Margaret Greenfield/Carmel Cohen, MD “Excellence in Ovarian Cancer Research Award,” the GCF/Claudia Cohen Research Foundation Prize, and the Charles A. Hunter, Jr. Prize Thesis Award. He is a full member of several organizations, including the Society of Gynecologic Oncologists and the American Association for Cancer Research.

Spotlight

Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.

Awareness

Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.

Research

The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.

Education

The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.